Ablation of somatostatin cells leads to impaired pancreatic islet function and neonatal death in rodents

[1]  Huili Hu,et al.  A cullin 4B-RING E3 ligase complex fine-tunes pancreatic &dgr; cell paracrine interactions , 2017, The Journal of clinical investigation.

[2]  S. Ellard,et al.  Atypical Forms of Congenital Hyperinsulinism in Infancy Are Associated With Mosaic Patterns of Immature Islet Cells , 2017, The Journal of clinical endocrinology and metabolism.

[3]  Y. Taché,et al.  Activation of Brain Somatostatin Signaling Suppresses CRF Receptor-Mediated Stress Response , 2017, Front. Neurosci..

[4]  Xiao-Jing Wang,et al.  Adaptive Activation of a Stress Response Pathway Improves Learning and Memory Through Gs and β-Arrestin-1–Regulated Lactate Metabolism , 2017, Biological Psychiatry.

[5]  Alex R. B. Thomsen,et al.  Arrestin-biased AT1R agonism induces acute catecholamine secretion through TRPC3 coupling , 2017, Nature Communications.

[6]  N. Irwin,et al.  Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival , 2016, Molecular and Cellular Endocrinology.

[7]  D. M. Smith,et al.  Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes , 2016, Cell metabolism.

[8]  C. Donaldson,et al.  Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets , 2016, Molecular metabolism.

[9]  C. Stanley.  Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders. , 2016, The Journal of clinical endocrinology and metabolism.

[10]  D. Eizirik,et al.  Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin , 2016, Molecular Imaging and Biology.

[11]  Q. Pang,et al.  Different downstream signalling of CCK1 receptors regulates distinct functions of CCK in pancreatic beta cells , 2015, British journal of pharmacology.

[12]  D. Hay,et al.  Amylin: Pharmacology, Physiology, and Clinical Potential , 2015, Pharmacological Reviews.

[13]  M. Bugliani,et al.  Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms , 2015, Diabetologia.

[14]  C. Donaldson,et al.  Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion , 2015, Nature Medicine.

[15]  S. Cross,et al.  Altered Phenotype of β-Cells and Other Pancreatic Cell Lineages in Patients With Diffuse Congenital Hyperinsulinism in Infancy Caused by Mutations in the ATP-Sensitive K-Channel , 2015, Diabetes.

[16]  T. Chen,et al.  A stress response pathway in mice upregulates somatostatin level and transcription in pancreatic delta cells through Gs and β-arrestin 1 , 2014, Diabetologia.

[17]  K. Kaestner,et al.  The diabetes gene Hhex maintains δ-cell differentiation and islet function , 2014, Genes & development.

[18]  C. Gragnoli.  Hypothesis of the neuroendocrine cortisol pathway gene role in the comorbidity of depression, type 2 diabetes, and metabolic syndrome , 2014, The application of clinical genetics.

[19]  R. Batterham,et al.  The role of gut hormone peptide YY in energy and glucose homeostasis: twelve years on. , 2014, Annual review of physiology.

[20]  T. Horvath,et al.  Neonatal Insulin Action Impairs Hypothalamic Neurocircuit Formation in Response to Maternal High-Fat Feeding , 2014, Cell.

[21]  P. MacDonald,et al.  SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells. , 2012, American journal of physiology. Endocrinology and metabolism.

[22]  F. Ashcroft,et al.  Diabetes Mellitus and the β Cell: The Last Ten Years , 2012, Cell.

[23]  C. Sempoux,et al.  Morphological mosaicism of the pancreatic islets: a novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy. , 2011, The Journal of clinical endocrinology and metabolism.

[24]  M. D. De Martino,et al.  Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome , 2010, Neuroendocrinology.

[25]  C. Tei,et al.  Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth hormone-releasing peptide-2 (GHRP-2), corticotropin-releasing hormone (CRH) and insulin-induced hypoglycemia in patients with hypothalamopituitary disorders: evidence for direct ACTH releasing activity of GHRP-2. , 2010, Endocrine journal.

[26]  C. C. Richardson,et al.  Somatostatin Secreted by Islet δ-Cells Fulfills Multiple Roles as a Paracrine Regulator of Islet Function , 2009, Diabetes.

[27]  A. Goodchild,et al.  Somatostatin 2A Receptor–Expressing Presympathetic Neurons in the Rostral Ventrolateral Medulla Maintain Blood Pressure , 2008, Hypertension.

[28]  Qinghua Wang,et al.  Insulin as a physiological modulator of glucagon secretion. , 2008, American journal of physiology. Endocrinology and metabolism.

[29]  J. Bryan,et al.  Neonatal diabetes mellitus. , 2008, Endocrine reviews.

[30]  R. Enriquez,et al.  Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity , 2006, Diabetologia.

[31]  J. Martinez-Barbera,et al.  In vivo genetic ablation by Cre‐mediated expression of diphtheria toxin fragment A , 2005, Genesis.

[32]  P. Serup,et al.  The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the α- and β-cell lineages in the mouse endocrine pancreas , 2005, Development.

[33]  S. Theander,et al.  β-Cell Secretory Products Activate α-Cell ATP-Dependent Potassium Channels to Inhibit Glucagon Release , 2005 .

[34]  Ahmed Mansouri,et al.  Opposing actions of Arx and Pax4 in endocrine pancreas development. , 2003, Genes & development.

[35]  M. Low,et al.  Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth. , 2001, The Journal of clinical investigation.

[36]  Paul A. Smith,et al.  Somatostatin activates two types of inwardly rectifying K+ channels in MIN‐6 cells , 2001, The Journal of physiology.

[37]  M. Stoffel,et al.  Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Betsholtz,et al.  Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). , 1998, Biochemical and biophysical research communications.

[39]  P. Gruss,et al.  The Pax4 gene is essential for differentiation of insulin-producing β cells in the mammalian pancreas , 1997, Nature.

[40]  P. Rorsman,et al.  Neurotransmitter-Induced Inhibition of Exocytosis in Insulin-Secreting β Cells by Activation of Calcineurin , 1996, Neuron.

[41]  F. Sundler,et al.  Islet amyloid polypeptide gene expression in the endocrine pancreas of the rat: a combined in situ hybridization and immunocytochemical study , 1993, Cell and Tissue Research.

[42]  D. Kunze,et al.  Somatostatin inhibits insulin secretion by a G-protein-mediated decrease in Ca2+ entry through voltage-dependent Ca2+ channels in the beta cell. , 1991, The Journal of biological chemistry.

[43]  K. Becker,et al.  The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? , 1984, Diabetologia.

[44]  D. Coy,et al.  Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat , 1982, Peptides.

[45]  J. Lowenberg,et al.  THE LAST TEN YEARS , 2012 .

[46]  Y. Zhang,et al.  Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. , 2006, Cell metabolism.

[47]  S. Theander,et al.  Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release. , 2005, Diabetes.

[48]  R. M. Shepherd,et al.  Hyperinsulinism in infancy: from basic science to clinical disease. , 2004, Physiological reviews.

[49]  H. Wilkinson,et al.  Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis. , 2003, Molecular endocrinology.

[50]  J. Gerich,et al.  Hypoglycemia unawareness. , 1991, Endocrine reviews.